Alnylam Pharmaceuticals
ALNY
#620
Rank
S$43.56 B
Marketcap
$336.52
Share price
4.69%
Change (1 day)
70.72%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company